Cancer News and Research

Latest Cancer News and Research

Study examines lifestyle-related causes of death in AIDS patients

The study, by researchers from the University of Bristol and a large group of international collaborators, examined data from the Antiretroviral Therapy Cohort Collaboration (ART-CC) which involved nearly 40,000 patients who started ART between 1996 and 2006 in Europe and North America.

29 Apr 2010

ECRI Institute's recommendations for controlling CT radiation dose

The benefits of computed tomography (CT) have increased greatly over the past decade. Now twice as powerful, it offers dynamic images of anatomy, including the beating heart. Future advancements promise to deliver even more clinical benefits. However, CT has always had a downside: it can deliver high radiation doses to patients, putting them at increased risk of developing cancer.

29 Apr 2010

Presence and type of cirrhosis complications are strong predictors of mortality: Study

A recent study by Danish researchers discovered patients with alcoholic cirrhosis had a high prevalence of complications at the time of the disease diagnosis.

29 Apr 2010

Nearly all U.S. states offer HPV vaccine to adolescent girls in juvenile justice facilities: Report

Nearly all U.S. states offer the human papillomavirus vaccine to adolescent girls who have been arrested or detained, according to a new report from The Miriam Hospital and Brown University. The study, published in the May issue of the Journal of Adolescent Health, offers the first nationwide review of HPV vaccination practices among juvenile justice facilities.

29 Apr 2010

LCA acknowledges on-going work by ODP on lung cancer screening research

Lung Cancer Alliance acknowledges the on-going work by the Office of Disease Prevention at the National Institutes of Health on lung cancer screening research and the need for people who may be at risk for lung cancer to be well informed.

29 Apr 2010

Fluorescent inhibitors hold promise for early-stage tumor detection

A series of novel imaging agents could light up tumors as they begin to form - before they turn deadly - and signal their transition to aggressive cancers.

29 Apr 2010

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.

29 Apr 2010

Study: Curcumin nanoparticles limit toxicity of cancer therapy

Pre-treatment with curcumin, a component of the spice turmeric, makes ovarian cancer cells more vulnerable to chemotherapy and radiotherapy. Researchers writing in BioMed Central's open access Journal of Ovarian Research found that delivering the curcumin via very small (less than 100nm) nanoparticles enhanced the sensitizing effect.

29 Apr 2010

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.

29 Apr 2010

Study calls for optimized medical treatment for older patients with advanced lung cancer

Although more than two fifths of lung cancers are diagnosed in patients over 70, data from clinical trials on the safest and most effective treatments for this age group are scarce.

29 Apr 2010

A new approach for treating neurological and degenerative disorders

In studies on cancer, heart disease, neurological disorders and other degenerative conditions, some scientists are moving away from the "nature versus nurture" debate, and are finding you're not a creature of either genetics or environment, but both - with enormous implications for a new approach to health.

29 Apr 2010

Three new biomarkers for ductal carcinoma in situ found

A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.

29 Apr 2010

Tumor cell factories may be difficult to defeat: Researchers

Many of the colon cancer cells that form tumors can be killed by genetically short-circuiting the cells' ability to absorb a key nutrient, a new study has found. While the findings are encouraging, the test tube study using human colon cancer cells also illustrates the difficulty of defeating these cells, known as cancer stem cells.

29 Apr 2010

Imaging costs for Medicare cancer patients on the rise

A study in the Journal of the American Medical Association analyzed data from Medicare cancer patients to determine the change in imaging use for this group.

29 Apr 2010

Investigators study Pioglitazone and Vitamin E for treatment of NASH

A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis, according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. Results were published April 28 online in the New England Journal of Medicine.

29 Apr 2010

Neoprobe reports revenues of $2.7M for first-quarter 2010

Neoprobe Corporation, a diversified developer of innovative biomedical surgical oncology products, today announced consolidated results for the first quarter of 2010. First quarter 2010 revenues were $2.7 million, consistent with the record revenue reported for the first quarter of 2009.

29 Apr 2010

Goodwin Biotechnology, Hyprocell sign collaborative agreement to strengthen clinical development services

Goodwin Biotechnology Inc., a full service contract biomanufacturing company, and Hyprocell LLC, a clinical cell line development services company, jointly announced today their collaborative agreement to create a business model enabling customers to access their one stop shop services.

28 Apr 2010

More taxes and drab packages for cigarettes to deter the young from smoking

From 1st July 2012 companies making cigarettes will be allowed only to have a brand name and a graphic health warning on their cigarette packs. There has been a huge debate over this issue. Trade experts believe that this move could mean that the Federal Government may have to cough up more than $3 billion a year to cigarette companies. Tim Wilson from the Institute of Public Affairs also believes that this would cost taxpayers $3.4 billion a year in compensation to tobacco companies. However Australia will be the first country to introduce such a measure.

28 Apr 2010

Celera reports net loss of $12.5M for first-quarter 2010

Celera Corporation today reported net revenues of $31.4 million for the first quarter of 2010 that ended March 27, 2010, compared to $45.7 million in the prior year quarter. For the first quarter of 2010, Celera reported a net loss $12.5 million, or $0.15 per share, compared to a net loss of $1.4 million, or $0.02 per share, for the prior year quarter.

28 Apr 2010

Positive results from interim analysis of ongoing Phase 2a study of BCX4208

BioCryst Pharmaceuticals, Inc. announced positive top-line results from a planned interim analysis of its ongoing Phase 2a, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of orally administered BCX4208 in patients with gout.

28 Apr 2010

Cancer News and Research

Latest Cancer News and Research

Study examines lifestyle-related causes of death in AIDS patients

ECRI Institute's recommendations for controlling CT radiation dose

Presence and type of cirrhosis complications are strong predictors of mortality: Study

Nearly all U.S. states offer HPV vaccine to adolescent girls in juvenile justice facilities: Report

LCA acknowledges on-going work by ODP on lung cancer screening research

Fluorescent inhibitors hold promise for early-stage tumor detection

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Study: Curcumin nanoparticles limit toxicity of cancer therapy

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

Study calls for optimized medical treatment for older patients with advanced lung cancer

A new approach for treating neurological and degenerative disorders

Three new biomarkers for ductal carcinoma in situ found

Tumor cell factories may be difficult to defeat: Researchers

Imaging costs for Medicare cancer patients on the rise

Investigators study Pioglitazone and Vitamin E for treatment of NASH

Neoprobe reports revenues of $2.7M for first-quarter 2010

Goodwin Biotechnology, Hyprocell sign collaborative agreement to strengthen clinical development services

More taxes and drab packages for cigarettes to deter the young from smoking

Celera reports net loss of $12.5M for first-quarter 2010

Positive results from interim analysis of ongoing Phase 2a study of BCX4208

Cancer Research - Second Edition eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in